• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

系统性硬化症和雷诺综合征患者中前列环素代谢产物增加及红细胞变形性降低。

Increased prostacyclin metabolites and decreased red cell deformability in patients with systemic sclerosis and Raynauds syndrome.

作者信息

Belch J J, McLaren M, Anderson J, Lowe G D, Sturrock R D, Capell H A, Forbes C D

出版信息

Prostaglandins Leukot Med. 1985 Jan;17(1):1-9. doi: 10.1016/0262-1746(85)90029-0.

DOI:10.1016/0262-1746(85)90029-0
PMID:3883365
Abstract

Patients with systemic sclerosis (SS) often suffer from Raynaud's Syndrome (RS). As prostacyclin (PGI2) is of benefit in the treatment of RS in SS, we have measured endogenous stable metabolites of PGI2 (PGI2m) in 42 patients with Raynaud's Phenomenon (RP) of varying aetiology (15 SS patients, 15 patients with Raynaud's Disease (RD) but no other symptoms, and 12 other RS patients with probable connective tissue disorder). Results were compared with 15 matched controls. Since abnormally rigid red blood cells (RBC) may occur in SS, we also measured RBC deformability (filtration technique). Results show that the SS group have significantly elevated PGI2m levels compared to patients with RD alone and normal controls. In addition, SS patients have more rigid RBC. If all 42 patients with RS were analysed, a significant correlation between PGF and RBC filtration was obtained. The cells of SS patients are resistant to the effects of PGI2 and it would appear that as a compensatory mechanism, production of PGI2 is increased. Treatment with exogenous PGI2 may overcome this resistance and improve microcirculatory flow. The more rigid RBC in SS may also be related to the increased endogenous PGI2. These results may have important clinical implications and allow new therapeutic approaches.

摘要

系统性硬化症(SS)患者常伴有雷诺氏综合征(RS)。由于前列环素(PGI2)对治疗SS中的RS有益,我们测定了42例不同病因的雷诺现象(RP)患者(15例SS患者、15例仅有雷诺氏病(RD)但无其他症状的患者以及12例可能患有结缔组织病的其他RS患者)体内PGI2的内源性稳定代谢产物(PGI2m)。将结果与15例匹配的对照进行比较。由于SS患者可能出现异常僵硬的红细胞(RBC),我们还测定了RBC的变形性(过滤技术)。结果显示,与单纯RD患者和正常对照相比,SS组的PGI2m水平显著升高。此外,SS患者的RBC更僵硬。如果对所有42例RS患者进行分析,PGF与RBC过滤之间存在显著相关性。SS患者的细胞对PGI2的作用具有抗性,似乎作为一种代偿机制,PGI2的产生增加。外源性PGI2治疗可能克服这种抗性并改善微循环血流。SS中更僵硬的RBC也可能与内源性PGI2增加有关。这些结果可能具有重要的临床意义,并为新的治疗方法提供依据。

相似文献

1
Increased prostacyclin metabolites and decreased red cell deformability in patients with systemic sclerosis and Raynauds syndrome.系统性硬化症和雷诺综合征患者中前列环素代谢产物增加及红细胞变形性降低。
Prostaglandins Leukot Med. 1985 Jan;17(1):1-9. doi: 10.1016/0262-1746(85)90029-0.
2
Increased prostacyclin metabolites and decreased red cell deformability in patients with systemic sclerosis and Raynaud's syndrome.系统性硬化症和雷诺综合征患者中前列环素代谢产物增加及红细胞变形性降低。
Prostaglandins Leukot Med. 1985 Jun;18(3):401-2. doi: 10.1016/0262-1746(85)90073-3.
3
Serum from patients with Raynaud's phenomenon inhibits prostacyclin production.雷诺现象患者的血清会抑制前列环素的生成。
J Invest Dermatol. 1987 Dec;89(6):555-9. doi: 10.1111/1523-1747.ep12461206.
4
Differences in red cell behaviour between patients with Raynaud's phenomenon and systemic sclerosis and patients with Raynaud's disease.雷诺现象和系统性硬化症患者与雷诺病患者红细胞行为的差异。
Br J Dermatol. 1985 Sep;113(3):265-72. doi: 10.1111/j.1365-2133.1985.tb02077.x.
5
Effect of prostaglandins I2 and E1 on red cell deformability in patients with Raynaud's phenomenon and systemic sclerosis.前列腺素I2和E1对雷诺现象及系统性硬化症患者红细胞变形性的影响。
Br Med J (Clin Res Ed). 1981 Aug 1;283(6287):350. doi: 10.1136/bmj.283.6287.350.
6
Platelet sensitivity to a prostacyclin analogue in systemic sclerosis.系统性硬化症中血小板对前列环素类似物的敏感性
Br J Rheumatol. 1985 Nov;24(4):346-50. doi: 10.1093/rheumatology/24.4.346.
7
The pharmacological effects of cicaprost, an oral prostacyclin analogue, in patients with Raynaud's syndrome secondary to systemic sclerosis--a preliminary study.口服前列环素类似物西卡前列素对系统性硬化症继发雷诺综合征患者的药理作用——一项初步研究。
Clin Exp Rheumatol. 1991 May-Jun;9(3):271-3.
8
Baseline plasma fibrinolysis and its correlation with clinical manifestations in patients with Raynaud's phenomenon.雷诺现象患者的基线血浆纤维蛋白溶解及其与临床表现的相关性。
Ann Rheum Dis. 1993 Jun;52(6):443-8. doi: 10.1136/ard.52.6.443.
9
Plasma eicosanoids, platelet function and cold sensitivity.血浆类二十烷酸、血小板功能与冷敏感性。
Br J Surg. 1989 Apr;76(4):401-5. doi: 10.1002/bjs.1800760430.
10
Abnormal biochemical and cellular parameters in the blood of patients with Raynauds phenomenon.雷诺现象患者血液中的异常生化和细胞参数。
Scott Med J. 1987 Feb;32(1):12-4. doi: 10.1177/003693308703200106.

引用本文的文献

1
Pharmacotherapy of Raynaud's phenomenon.雷诺现象的药物治疗。
Drugs. 1996 Nov;52(5):682-95. doi: 10.2165/00003495-199652050-00006.
2
Raynaud's phenomenon: its relevance to scleroderma.雷诺现象:其与硬皮病的相关性。
Ann Rheum Dis. 1991 Nov;50 Suppl 4(Suppl 4):839-45. doi: 10.1136/ard.50.suppl_4.839.
3
A double blind, randomised, multicentre comparison of two doses of intravenous iloprost in the treatment of Raynaud's phenomenon secondary to connective tissue diseases.两剂量静脉注射伊洛前列素治疗结缔组织病继发雷诺现象的双盲、随机、多中心比较
Ann Rheum Dis. 1991 Nov;50(11):800-4. doi: 10.1136/ard.50.11.800.